BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21870899)

  • 1. Discontinued drugs in 2010: cardiovascular drugs.
    Zhao HP; Zhang XS; Xiang BR
    Expert Opin Investig Drugs; 2011 Oct; 20(10):1311-25. PubMed ID: 21870899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinued drugs in 2008: cardiovascular drugs.
    Zhang XS; Xiang BR
    Expert Opin Investig Drugs; 2009 Jul; 18(7):875-85. PubMed ID: 19548849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinued drugs in 2011: cardiovascular drugs.
    Zhao HP; Jiang HM; Xiang BR
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1449-62. PubMed ID: 22827213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis.
    Antoniu SA
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1607-18. PubMed ID: 22839355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinued drugs 2008: pulmonary and allergy.
    Antoniu SA
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1799-805. PubMed ID: 19852567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinued drugs 2010: rheumatology, allergy and dermatology, pulmonary.
    Antoniu SA
    Expert Opin Investig Drugs; 2011 Sep; 20(9):1175-87. PubMed ID: 21793791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinued drugs in 2007: cardiovascular drugs.
    Zhang XS; Xiang BR
    Expert Opin Investig Drugs; 2008 Dec; 17(12):1817-28. PubMed ID: 19012498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinued drugs in 2010: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinued drugs in 2008: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1581-94. PubMed ID: 19663760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinued cardiovascular drugs in 2013 and 2014.
    Zhao HP; Xiang BR
    Expert Opin Investig Drugs; 2015; 24(8):1083-92. PubMed ID: 26162717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinued drugs in 2006: cardiovascular drugs translational medicine perspective.
    Feuerstein GZ; Ruffolo RR
    Expert Opin Investig Drugs; 2007 Sep; 16(9):1315-26. PubMed ID: 17714019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinued drugs in 2006: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2008 Mar; 17(3):269-83. PubMed ID: 18321227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinued drugs in 2005: cardiovascular drugs.
    Suckling K
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1299-308. PubMed ID: 17040192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinued drugs in 2012: cardiovascular drugs.
    Zhao HP; Jiang HM; Xiang BR
    Expert Opin Investig Drugs; 2013 Nov; 22(11):1437-51. PubMed ID: 23992034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The odyssey of marine pharmaceuticals: a current pipeline perspective.
    Mayer AM; Glaser KB; Cuevas C; Jacobs RS; Kem W; Little RD; McIntosh JM; Newman DJ; Potts BC; Shuster DE
    Trends Pharmacol Sci; 2010 Jun; 31(6):255-65. PubMed ID: 20363514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow start to phase 0 as researchers debate value.
    Twombly R
    J Natl Cancer Inst; 2006 Jun; 98(12):804-6. PubMed ID: 16788150
    [No Abstract]   [Full Text] [Related]  

  • 17. European Society of Cardiology--2009 annual congress. 31 August - 2 September 2009, Barcelona, Spain.
    Wong NC
    IDrugs; 2009 Nov; 12(11):675-8. PubMed ID: 19844849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinued drugs in 2007: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2008 Dec; 17(12):1791-816. PubMed ID: 19012497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New medicines in development for AIDS: 1994 survey from the Pharmaceutical Research and Manufacturers of America.
    Pediatr AIDS HIV Infect; 1995 Apr; 6(2):101-10. PubMed ID: 11361382
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
    Kinders R; Parchment RE; Ji J; Kummar S; Murgo AJ; Gutierrez M; Collins J; Rubinstein L; Pickeral O; Steinberg SM; Yang S; Hollingshead M; Chen A; Helman L; Wiltrout R; Simpson M; Tomaszewski JE; Doroshow JH
    Mol Interv; 2007 Dec; 7(6):325-34. PubMed ID: 18199854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.